The helicobacter pylori (H. pylori) non-invasive testing market in Middle East & Africa is expected to grow from US$ 39.86 million in 2022 to US$ 54.80 million by 2028. It is estimated to grow at a CAGR of 5.4% from 2022 to 2028.

Diagnosis for Resistance

Diagnosis for Antibiotic-Resistant Infections to Bolster Helicobacter Pylori (H. pylori) Non-invasive Testing Market Growth in Middle East & Africa during Forecast Period

The limited success rate of the treatment of H. pylori infection is mainly due to resistance to clarithromycin and metronidazole. Therefore, research will be focused on the identification of bacterial resistance. Smart Gene was developed based on the concept of point of care genetic testing. A recent study has shown that H. pylori DNA can be detected in human stool specimens with PCR tests using stool specimens. The novel PCR test can sensitively detect H. pylori DNA in stool, along with mutations causing clarithromycin resistance. There is a significant correlation between the presence of such mutations and the outcome of clarithromycin-based eradication treatment. The consequences of this study suggest that stool can be used to determine resistance with a high correlation to eradication status. This stool/PCR test can potentially reduce healthcare costs with an updated algorithm.

Market Overview

The UAE has witnessed significant growth in the Helicobacter pylori (H. pylori) non-invasive testing market over the past few years. The market growth in the UAE is attributed to the increase in healthcare expenditure and the high prevalence of stomach cancer. According to the NIH report, stomach cancer is the most common type of cancer in the country. Additionally, stomach cancer is a significant contributor to the global burden of stomach cancer morbidity and mortality.

The survey conducted by Gulf news in 2019 revealed that 88% of UAE citizens do not visit clinics or hospitals for preventive screening for cancer. A few factors limiting the early screening of cancer include the cost of screening, cultural sensitivities, and psychological denial about the disease. The prevalence of cancer and high healthcare expenditure are expected to boost the growth of the Helicobacter pylori (H. pylori) non-invasive testing market in the UAE during the forecast period.

Middle East & Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market Segmentation

The Middle east & Africa helicobacter pylori (H. pylori) non-invasive testing market is segmented on test type, test method, end user, and country.
Based on test type, the Middle east & Africa Helicobacter pylori (H. pylori) non-invasive testing market is segmented into serology, stool antigen, and urea breathe. In 2022, the urea breath segment is expected to hold the largest share of the market. Based on test method, the Middle east & Africa Helicobacter pylori (H. pylori) non-invasive testing market is bifurcated into laboratory based and point of care. The laboratory based segment is expected to hold a larger share of the market in 2022. Based on end user, the Middle east & Africa Helicobacter pylori (H. pylori) non-invasive testing market is segmented into hospitals, clinics, and diagnostic laboratories. The diagnostic laboratories segment is expected to hold the largest share of the market in 2022. Based on country, the Middle East & Africa Helicobacter pylori (H. pylori) non-invasive testing market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Further, UAE dominated the market in 2022. Abbott Laboratories; Bio-Rad Laboratories Inc.; CerTest Biotec; Coris BioConcept; DiaSorin S.p.A.; Meridian Bioscience Inc.; QuidelOrtho Corporation; Sekisui Diagnostics; Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd; and Thermo Fisher Scientific Inc. are the leading companies operating in the helicobacter pylori (H. pylori) non-invasive testing market in the Middle East & Africa.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Helicobacter Pylori (H. pylori ) Non-invasive Testing Market – By Test Type
1.3.2 MEA Helicobacter Pylori (H. pylori) Non-invasive Testing Market – By Test Method
1.3.3 MEA Helicobacter Pylori (H. pylori) Non-invasive Testing Market – By End User
1.3.4 MEA Helicobacter Pylori (H. pylori ) Non-invasive Testing Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Helicobacter Pylori (H. pylori ) Non-invasive Testing Market – Market Landscape
4.1 Overview
4.2 MEA PEST Analysis
4.3 Experts Opinion
5. MEA Helicobacter Pylori (H. pylori ) Non-Invasive Testing Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing prevalence of H. pylori bacterial infection
5.1.2 New Product Launches & FDA Approvals for Noninvasive Tests
5.1.3 Spreading Awareness Among Individuals Regarding Diagnosis of H. pylori
5.1.4 Rise in Investments by Pharmaceutical Companies
5.2 Key Market Restraints
5.2.1 Low Diagnosis Rate
5.3 Key Market Opportunities
5.3.1 Increasing Number of Conferences and Events for Research
5.3.2 Introduction of Artificial Intelligence
5.4 Future Trends
5.4.1 Increasing Use of Home-Based POC Devices
5.4.2 Diagnosis for Resistance
5.5 Impact Analysis
6. Helicobacter pylori (H. pylori ) Non-Invasive Testing Market– Global Analysis
6.1 Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue Forecast and Analysis
7. MEA Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Analysis– by Test Type
7.1 Overview
7.2 MEA Helicobacter pylori (H. pylori ) Non-invasive Testing Market, By Test Type 2022 & 2028 (%)
7.3 Serology Test
7.3.1 Overview
7.3.2 MEA Serology Test Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Stool Antigen Test
7.4.1 Overview
7.4.2 MEA Stool Antigen Test Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Urea Breath Test
7.5.1 Overview
7.5.2 MEA Urea Breath Test Market Revenue and Forecasts to 2028 (US$ Mn)
8. MEA Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Analysis– by Test Method
8.1 Overview
8.2 MEA Helicobacter pylori (H. pylori) Non-invasive Testing Market, By Test Method 2022 & 2028 (%)
8.3 Laboratory Based Tests
8.3.1 Overview
8.3.2 MEA Laboratory Based Tests Market Revenue and Forecasts to 2028 (US$ Mn)
8.4 Point Of Care Tests
8.4.1 Overview
8.4.2 MEA Point of Care Tests Market Revenue and Forecasts to 2028 (US$ Mn)
9. MEA Helicobacter pylori (H. pylori ) Non-invasive Testing Market Analysis– by End User
9.1 Overview
9.2 MEA Helicobacter pylori (H. pylori ) Non-invasive Testing Market, By End User 2018 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 MEA Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
9.4 Clinics
9.4.1 Overview
9.4.2 MEA Clinics Market Revenue and Forecasts to 2028 (US$ Mn)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 MEA Diagnostic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
10. MEA Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028 – Country Analysis
10.1 Overview
10.1.1 MEA: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, by Country, 2022 & 2028 (%)
10.1.1.1 UAE: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.1 Overview
10.1.1.1.2 UAE: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 UAE: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
10.1.1.1.4 UAE: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts To 2028, By Test Method (US$ Million)
10.1.1.1.5 UAE: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts To 2028, By End User (US$ Million)
10.1.1.2 Saudi Arabia: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.1 Overview
10.1.1.2.2 Saudi Arabia Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Saudi Arabia: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
10.1.1.2.4 Saudi Arabia: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts To 2028, By Test Method (US$ Million)
10.1.1.2.5 Saudi Arabia: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts To 2028, By End User (US$ Million)
10.1.1.3 South Africa: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.1 Overview
10.1.1.3.2 South Africa Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 South Africa: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
10.1.1.3.4 South Africa: Helicobacter Pylori (H. Pylori ) Market Revenue and Forecasts To 2028, By Test Method (US$ Million)
10.1.1.3.5 South Africa: Helicobacter Pylori (H. Pylori ) Market Revenue and Forecasts To 2028, By End User (US$ Million)
10.1.1.4 Rest of the Middle East and Africa: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of the Middle East and Africa Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Rest of MEA: Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
10.1.1.4.4 Rest of MEA: Helicobacter Pylori (H. Pylori ) Market Revenue and Forecasts To 2028, By Test Method (US$ Million)
10.1.1.4.5 Rest of MEA: Helicobacter Pylori (H. Pylori ) Market Revenue and Forecasts To 2028, By End User (US$ Million)
11. Helicobacter Pylori (H. Pylori ) Non-Invasive Testing Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Helicobacter Pylori (H. Pylori ) Non-Invasive Testing Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profile
12.1 DiaSorin S.p.A.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Meridian Bioscience, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QuidelOrtho Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Abbott Laboratories
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 CerTest Biotec
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Sekisui Diagnostics
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Coris BioConcept
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Bio-Rad Laboratories, Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms

LIST OF TABLES

Table 1. UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 2. UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Method (US$ Million)
Table 3. UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 4. Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 5. Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Method (US$ Million)
Table 6. Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 7. South Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 8. South Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts to 2028, By Test Method (US$ Million)
Table 9. South Africa: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 10. Rest of MEA: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 11. Rest of MEA: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts to 2028, By Test Method (US$ Million)
Table 12. Rest of MEA: Helicobacter Pylori (H. Pylori) Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 13. Recent Inorganic Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market
Table 14. Recent Organic Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market
Table 15. Glossary of Terms

LIST OF FIGURES

Figure 1. MEA Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Segmentation
Figure 2. MEA Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, By Country
Figure 3. MEA Helicobacter Pylori (H. pylori) Non-invasive Testing Market Overview
Figure 4. Urea Breath Segment Held Largest Share of Test Type Segment in MEA Helicobacter Pylori (H. pylori) Non-invasive Testing Market
Figure 5. South Africa is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. MEA: PEST Analysis
Figure 7. Experts Opinion
Figure 8. MEA Helicobacter pylori Non-Invasive Testing Market Impact Analysis of Driver and Restraints
Figure 9. Global Helicobacter pylori (H. pylori) Non-Invasive Testing Market– Revenue Forecast and Analysis – 2020 – 2028
Figure 10. MEA Helicobacter pylori (H. pylori) Noninvasive Testing Market, by Test Type 2022 & 2028 (%)
Figure 11. MEA Serology Test Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. MEA Stool Antigen Test Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. MEA Urea Breath Test Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. MEA Helicobacter pylori (H. pylori) Noninvasive Testing Market, by Test Method 2022 & 2028 (%)
Figure 15. MEA Laboratory Based Tests Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. MEA Point of Care Tests Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. MEA Helicobacter pylori (H. pylori) Noninvasive Testing Market, by End User 2018 & 2028 (%)
Figure 18. MEA Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. MEA Clinics Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. MEA Diagnostic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. MEA Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue Overview, by Country, 2022 (US$ Million)
Figure 22. MEA: Helicobacter Pylori (H. pylori) Non-invasive Testing Market, by Country, 2022 & 2028 (%)
Figure 23. UAE: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 24. Saudi Arabia: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. South Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. Rest of the Middle East and Africa: Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa helicobacter pylori (H. pylori) non-invasive testing market
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa helicobacter pylori (H. pylori) non-invasive testing market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the helicobacter pylori (H. pylori) non-invasive testing market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

The List of Companies – Middle East & Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market

● Abbott Laboratories
● Bio-Rad Laboratories Inc.
● CerTest Biotec; Coris BioConcept
● Coris BioConcept
● DiaSorin S.p.A.
● Meridian Bioscience Inc.
● QuidelOrtho Corporation
● Sekisui Diagnostics
● Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd
● Thermo Fisher Scientific Inc.

At 5.4% CAGR, the Middle East & Africa Helicobacter Pylori (H. pylori) Non-invasive Testing Market is speculated to be worth US$ 54.80 Million by 2028, says The Insight Partners

According to The Insight Partners’ research, the Middle East & Africa helicobacter pylori (H. pylori) non-invasive testing market was valued at US$ 39.86 million in 2022 and is expected to reach US$ 54.80 million by 2028, registering an annual growth rate of 5.4% from 2022 to 2028. Increasing use of home-based POC devices and new product launches & FDA approvals for noninvasive tests are the critical factors attributed to the market expansion.

The increasing awareness of Helicobacter pylori infections such as peptic ulcers and gastritis is bringing the test diagnostics kits conveniently and quickly to the patient at home. Most clinicians recognize POC testing as a requirement for the early detection of life-threatening situations because laboratory results can be made available in real-time. In low- and middle-income countries, POC diagnostic and monitoring devices are anticipated to become universal in-home setups and at doctor’s offices or hospitals.

In stool antigen testing (STA), there are two types of assays, quantitative enzyme immunoassays (EIA), which are analyzed in a laboratory setting, and qualitative immunochromatography assays (ICA), which are regularly used as a rapid test at home or in the clinic. Therefore, these factors mentioned above have increased the demand for POCs for diagnostic purposes.

On the contrary, very low diagnosis rate hurdles the growth of Middle East & Africa helicobacter pylori (H. pylori) non-invasive testing market.

Based on test type, the Middle East & Africa Helicobacter pylori (H. pylori) non-invasive testing market is segmented into serology, stool antigen, and urea breathe. In 2022, the urea breath segment is expected to hold the largest share of the market in 2022 with a share of 45.0%, amassing US$ 17.92 million. It is projected to garner US$ 25.13 million by 2028 to expand at 5.8% CAGR during 2022–2028. Based on test method, the Middle East & Africa Helicobacter pylori (H. pylori) non-invasive testing market is bifurcated into laboratory based and point of care. The laboratory based segment is expected to hold a larger share of the market in 2022 with a share of 75.5%, amassing US$ 30.11 million. It is projected to garner US$ 41.98 million by 2028 to expand at 5.7% CAGR during 2022–2028. Based on end user, the Middle East & Africa Helicobacter pylori (H. pylori) non-invasive testing market is segmented into hospitals, clinics, and diagnostic laboratories. The diagnostic laboratories segment is expected to hold the largest share of the market in 2022 with a share of 58.8%, amassing US$ 23.43 million. It is projected to garner US$ 32.78 million by 2028 to expand at 5.8% CAGR during 2022–2028. Our regional analysis states that UAE captured 41.6% market share in 2022. It was assessed at US$ 16.60 million in 2022 and is likely to hit US$ 22.22 million by 2028, exhibiting a CAGR of 5.0% during the forecast period.

Key players dominating the Middle East & Africa helicobacter pylori (H. pylori) non-invasive testing market are Abbott Laboratories; Bio-Rad Laboratories Inc.; CerTest Biotec; Coris BioConcept; DiaSorin S.p.A.; Meridian Bioscience Inc.; QuidelOrtho Corporation; Sekisui Diagnostics; Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd; and Thermo Fisher Scientific Inc.

Below are mentioned a few key market developments by major players:

In Dec 2021, Thermo Fisher Scientific Inc. announced that it has completed its acquisition of PPD, Inc. (Nasdaq: PPD), a leading global provider of clinical research services to the biopharma and biotech industry, for $17.4 billion. In April 2020, Meridian Bioscience, Inc. has completed the acquisition of Exalenz Bioscience Ltd., the Modiin, Israel-based provider of the BreathID Breath Test Systems, a urea breath test platform for the detection of Helicobacter pylori.